Credit Suisse Group set a €92.00 ($106.98) price objective on Fresenius Medical Care AG & Co. (Pref) (ETR:FME) in a report issued on Monday. The brokerage currently has a buy rating on the stock.

Several other brokerages have also recently commented on FME. Morgan Stanley set a €90.00 ($104.65) price target on Fresenius Medical Care AG & Co. (Pref) and gave the company a buy rating in a research note on Friday, September 15th. Nord/LB set a €93.00 ($108.14) price target on Fresenius Medical Care AG & Co. (Pref) and gave the company a buy rating in a research note on Thursday, November 2nd. Goldman Sachs Group, Inc. (The) set a €97.00 ($112.79) price target on Fresenius Medical Care AG & Co. (Pref) and gave the company a buy rating in a research note on Friday, September 29th. J P Morgan Chase & Co set a €106.40 ($123.72) price target on Fresenius Medical Care AG & Co. (Pref) and gave the company a buy rating in a research note on Wednesday, August 2nd. Finally, Berenberg Bank set a €95.60 ($111.16) price target on Fresenius Medical Care AG & Co. (Pref) and gave the company a buy rating in a research note on Tuesday, September 5th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and ten have assigned a buy rating to the company’s stock. Fresenius Medical Care AG & Co. (Pref) has a consensus rating of Buy and an average target price of €89.28 ($103.81).

Shares of Fresenius Medical Care AG & Co. (FME) opened at €83.06 ($96.58) on Monday. Fresenius Medical Care AG & Co. has a 12 month low of €70.69 ($82.20) and a 12 month high of €89.22 ($103.74).

TRADEMARK VIOLATION NOTICE: This article was originally reported by Watch List News and is the sole property of of Watch List News. If you are reading this article on another publication, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The correct version of this article can be accessed at https://www.watchlistnews.com/credit-suisse-group-reiterates-92-00-price-target-for-fresenius-medical-care-ag-co-pref-fme/1692053.html.

Fresenius Medical Care AG & Co. (Pref) Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. (Pref) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. (Pref) and related companies with Analyst Ratings Network's FREE daily email newsletter.